Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals

被引:30
作者
Derdeyn, CA
Costello, C
Kilby, JM
Sfakianos, G
Saag, MS
Kaslow, R
Bucy, RP
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA
关键词
D O I
10.1089/088922299310359
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stromal cell-derived factor 1 (SDF-1) is the natural ligand that recognizes CXCR4, which also serves as a coreceptor for some strains of HIV-1, In this study, we explored SDF-1 blood levels among HIV-1-infected individuals exhibiting a wide range of CD4(+) cell counts, Plasma or serum concentrations of SDF-1 protein were measured by ELISA in samples from 31 HIV-1-seronegative individuals and 79 HIV-1-infected subjects, Although SDF-1 protein levels were stable for months among seronegative individuals (mean intrasubject variation, 17%), the absolute values varied widely (0.28 to 106.5 ng/ml; mean, 25.6 ng/ml), In HIV-1-infected subjects, there was a direct correlation between SDF-1 level and CD4(+) cell count. Subjects with fewer than 50 CD4(+) cells per cubic microliter of blood had significantly lower mean SDF-1 levels (+/-SD) than did either HIV-1-infected subjects with higher CD4(+) cell counts or uninfected controls: CD4(+) cell count <50, mean SDF-1 level of 10.7 +/- 33.7, 50 < CD4(+) cell count <200, mean SDF-1 level of 12.9 +/- 19.0, 200 < CD4(+) cell count <500, mean SDF-1 level of 19.3 +/- 36.8; CD4(+) cell count >500, mean SDF-1 level of 18.5 +/- 25.2; uninfected control mean SDF-1 level, 25.6 +/- 34.7. No significant change in SDF-1 level was detected after administration of antiretroviral therapy in nine subjects with advanced disease (mean intrasubject variation, 43%), Analysis of SDF-1 mRNA expression in lymph nodes from HIV-1-infected subjects at different disease stages revealed that the medullary cords contained stromal cells that express SDF-1 mRNA, This preliminary analysis suggests a possible link between lower SDF-1 levels and disease progression.
引用
收藏
页码:1063 / 1071
页数:9
相关论文
共 72 条
[41]   The role of CCR5 and CCR2 polymorphisms in HTV-1 transmission and disease progression [J].
Michael, NL ;
Louie, LG ;
Rohrbaugh, AL ;
Schultz, KA ;
Dayhoff, DE ;
Wang, CE ;
Sheppard, HW .
NATURE MEDICINE, 1997, 3 (10) :1160-1162
[42]   CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION [J].
MIEDEMA, F ;
MEYAARD, L ;
KOOT, M ;
KLEIN, MR ;
ROOS, MTL ;
GROENINK, M ;
FOUCHIER, RAM ;
VANTWOUT, AB ;
TERSMETTE, M ;
SCHELLEKENS, PTA ;
SCHUITEMAKER, H .
IMMUNOLOGICAL REVIEWS, 1994, 140 :35-72
[43]   Genetic polymorphism of CCR5 gene and HIV disease:: the heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression [J].
Morawetz, RA ;
Rizzardi, GP ;
Glauser, D ;
Rutschmann, O ;
Hirschel, B ;
Perrin, L ;
Opravil, M ;
Flepp, M ;
von Overbeck, J ;
Glauser, MP ;
Ghezzi, S ;
Vicenzi, E ;
Poli, G ;
Lazzarin, A ;
Pantaleo, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3223-3227
[44]   The human CC chemokine receptor 5 (CCR5) gene -: Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons [J].
Mummidi, S ;
Ahuja, SS ;
McDaniel, BL ;
Ahuja, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30662-30671
[45]   Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression [J].
Mummidi, S ;
Ahuja, SS ;
Gonzalez, E ;
Anderson, SA ;
Santiago, EN ;
Stephan, KT ;
Craig, FE ;
O'Connell, P ;
Tryon, V ;
Clark, RA ;
Dolan, MJ ;
Ahuja, SK .
NATURE MEDICINE, 1998, 4 (07) :786-793
[46]   The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 [J].
Oberlin, E ;
Amara, A ;
Bachelerie, F ;
Bessia, C ;
Virelizier, JL ;
ArenzanaSeisdedos, F ;
Schwartz, O ;
Heard, JM ;
ClarkLewis, I ;
Legler, DF ;
Loetscher, M ;
Baggiolini, M ;
Moser, B .
NATURE, 1996, 382 (6594) :833-835
[47]   Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS [J].
OBrien, WA ;
Hartigan, PM ;
Martin, D ;
Esinhart, J ;
Hill, A ;
Benoit, S ;
Rubin, M ;
Lahart, C ;
Wray, N ;
Finegold, SM ;
George, WL ;
Dickinson, GM ;
Klimas, N ;
Diamond, G ;
ZollaPazner, SB ;
Jensen, PC ;
Hawkes, C ;
Oster, C ;
Gordin, F ;
Labriola, AM ;
Spivey, P ;
Matthews, T ;
Weinhold, K ;
Drusano, G ;
Egorin, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) :426-431
[48]   Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies [J].
Ostrowski, MA ;
Krakauer, DC ;
Li, YX ;
Justement, SJ ;
Learn, G ;
Ehler, LA ;
Stanley, SK ;
Nowak, M ;
Fauci, AS .
JOURNAL OF VIROLOGY, 1998, 72 (10) :7772-7784
[49]  
PANOSKALTSISMORTARI A, 1995, BIOTECHNIQUES, V18, P300
[50]   LYMPHOID ORGANS FUNCTION AS MAJOR RESERVOIRS FOR HUMAN-IMMUNODEFICIENCY-VIRUS [J].
PANTALEO, G ;
GRAZIOSI, C ;
BUTINI, L ;
PIZZO, PA ;
SCHNITTMAN, SM ;
KOTLER, DP ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9838-9842